Analysis of CD44 expression revealed significant elevation (p < 0.0001) in both CRC (61.89 ± 9.24) and UC (45.43 ± 7.42) groups in comparison with controls (14.93 ± 4.37). Here, CD44 is linked to colorectal carcinoma.